Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Vanda Pharmaceuticals Inc today announced that ownership of the US New Drug Application and Investigational New Drug Applications for PONVORY has been transferred to Vanda from a Johnson Johnson Company
Candel Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that the US Food and Drug Administration
Incyte today announced that it has completed its acquisition of Escient Pharmaceuticals a clinicalstage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuroimmune disorders The acquisition o...
Biogen Inc announced the European Commission has granted marketing authorization under exceptional circumstances and maintained orphan
JJP Biologics a privately held biopharmaceutical company developing innovative antibodybased therapies announced the European Medicines Agency
Milestone Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines today announced that the United States Food and Drug Administration
Rocket Pharmaceuticals Inc a fully integrated latestage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high
Biohaven Ltd a global clinicalstage biopharmaceutical company focused on the discovery development and commercialization of lifechanging therapies to treat
Celltrion today announced that the European Commission has approved Omlyclo an omalizumab biosimilar drug referring to Xolair Omlyclo is approved
BioThera Solutions a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars and global specialty generic and consumer healthcare medicines company
